MedImmune, the global biologics research and development arm of AstraZeneca, is pleased to announce its participation in the Brazilian government program, Science Without Borders.
Thirty Brazilian post-doctoral fellows will work at MedImmune’s three sites in Gaithersburg, Maryland, Mountain View, California and Cambridge, UK for a period of two years. The areas of research will include oncology, respiratory, inflammation and autoimmune diseases (RIA), cardiovascular and metabolic diseases (CVMD), infectious diseases, translational science, antibody discovery and protein engineering, and biopharmaceutical development.
{iframe}http://pipelinereview.com/index.php/2013121852985/More-News/ASTRAZENECAS-MEDIMMUNE-PARTNERS-WITH-BRAZILS-SCIENCE-WITHOUT-BORDERS-PROGRAM.html{/iframe}